Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Imiquimod for the Treatment of Oral Dysplastic Lesions With Clinical and Histologic Assessments

NCT07210775 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT07210775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07210775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Imiquimod for the Treatment of Oral Dysplastic Lesions With Clinical and Histologic Assessments
Lead sponsor
University of Southern California
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukoplakia, leukoplakia oral, oral dysplasia